Literature DB >> 15450957

On the mechanism of mitochondrial permeability transition induction by glycyrrhetinic acid.

Cristina Fiore1, Mauro Salvi, Mario Palermo, Giulietta Sinigaglia, Decio Armanini, Antonio Toninello.   

Abstract

Glycyrrhetinic acid (GE), the aglycone of glycyrrhizic acid, a triterpene glycoside which represents one of the main constituents of licorice root, induces an oxidative stress in liver mitochondria responsible for the induction of membrane permeability transition. In fact, GE, by interacting with the mitochondrial respiratory chain, generates hydrogen peroxide which in turn oxidizes critical thiol groups and endogenous pyridine nucleotides leading to the opening of the transition pore. Most likely the reactive group of GE is the carbonyl oxygen in C-11 which, by interacting mainly with a Fe/S centre of mitochondrial complex I, generates an oxygen-centered radical responsible for the pro-oxidant action.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15450957     DOI: 10.1016/j.bbabio.2004.05.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

1.  Anti-inflammatory Activity of Magnesium Isoglycyrrhizinate Through Inhibition of Phospholipase A2/Arachidonic Acid Pathway.

Authors:  Chunfeng Xie; Xiaoting Li; Jieshu Wu; Zhaofeng Liang; Feifei Deng; Wei Xie; Mingming Zhu; Jianyun Zhu; Weiwei Zhu; Shanshan Geng; Caiyun Zhong
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

Review 2.  The molecular composition of the mitochondrial permeability transition pore.

Authors:  Christopher P Baines
Journal:  J Mol Cell Cardiol       Date:  2009-02-20       Impact factor: 5.000

3.  Carbenoxolone induces permeability transition pore opening in rat mitochondria via the translocator protein TSPO and connexin43.

Authors:  Tamara Azarashvili; Yulia Baburina; Dmitry Grachev; Olga Krestinina; Vassilios Papadopoulos; John J Lemasters; Irina Odinokova; Georg Reiser
Journal:  Arch Biochem Biophys       Date:  2014-07-01       Impact factor: 4.013

4.  18β-Glycyrrhetinic acid inhibits methicillin-resistant Staphylococcus aureus survival and attenuates virulence gene expression.

Authors:  Danyelle R Long; Julia Mead; Jay M Hendricks; Michele E Hardy; Jovanka M Voyich
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

Review 5.  Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment.

Authors:  Gantumur Battogtokh; Yong-Yeon Cho; Joo Young Lee; Hye Suk Lee; Han Chang Kang
Journal:  Front Pharmacol       Date:  2018-08-17       Impact factor: 5.810

6.  Licocalchone-C extracted from Glycyrrhiza glabra inhibits lipopolysaccharide-interferon-γ inflammation by improving antioxidant conditions and regulating inducible nitric oxide synthase expression.

Authors:  Sara Franceschelli; Mirko Pesce; Isabella Vinciguerra; Alessio Ferrone; Graziano Riccioni; Antonia Patruno; Alfredo Grilli; Mario Felaco; Lorenza Speranza
Journal:  Molecules       Date:  2011-07-06       Impact factor: 4.411

7.  Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: structure-activity relationships.

Authors:  Jung-Chung Lin; Jaw-Ming Cherng; Man-Shan Hung; Lidia A Baltina; Lia Baltina; Rimma Kondratenko
Journal:  Antiviral Res       Date:  2008-03-31       Impact factor: 5.970

Review 8.  Traditional Uses, Bioactive Chemical Constituents, and Pharmacological and Toxicological Activities of Glycyrrhiza glabra L. (Fabaceae).

Authors:  Gaber El-Saber Batiha; Amany Magdy Beshbishy; Amany El-Mleeh; Mohamed M Abdel-Daim; Hari Prasad Devkota
Journal:  Biomolecules       Date:  2020-02-25

Review 9.  Glycyrrhizic acid as a multifunctional drug carrier - From physicochemical properties to biomedical applications: A modern insight on the ancient drug.

Authors:  O Yu Selyutina; N E Polyakov
Journal:  Int J Pharm       Date:  2019-01-25       Impact factor: 5.875

Review 10.  An Overview of Structurally Modified Glycyrrhetinic Acid Derivatives as Antitumor Agents.

Authors:  Bing Xu; Gao-Rong Wu; Xin-Yu Zhang; Meng-Meng Yan; Rui Zhao; Nan-Nan Xue; Kang Fang; Hui Wang; Meng Chen; Wen-Bo Guo; Peng-Long Wang; Hai-Min Lei
Journal:  Molecules       Date:  2017-06-02       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.